Serum uric acid in metabolic syndrome
Journal Title: International Journal of Medical Science and Public Health - Year 2014, Vol 3, Issue 5
Abstract
Background: The metabolic syndrome consists of a constellation of metabolic abnormalities including central obesity, hypertriglyceridemia, low high-density lipoprotein (HDL) cholesterol, hyperglycemia and hypertension. Aims & Objective: To study serum uric acid level in metabolic syndrome. Materials and Methods: The present study was conducted on fifty patients with metabolic syndrome as per IDF criteria and waist circumference, blood pressure, serum uric acid were estimated. Results: There is significant correlation found between serum uric acid levels and hypertension and also between serum uric acid levels and waist circumference of metabolic syndrome patients. Conclusion: Patients with higher serum uric acid levels has significant correlation with components of metabolic syndrome is one of the risk factor in development of atherosclerosis and cardiovascular disease
Authors and Affiliations
Madhuri Yalla, Tadepalli Vani, Sujatha Pasula
Keywords
Related Articles
- EP ID EP89891
- DOI 10.5455/ijmsph.2014.260220141
- Views 176
- Downloads 0
Adherence to therapeutic regimen among patients with cardiovascular diseases in selected community area Dehradun, Uttarakhand
Background: Adherence to therapeutic regimen is an important element of self-care behaviors in cardiac patient. Adherence simply means to which patients taking medication, following diet and changing lifestyle as recomme...
A prospective study of radiation-induced hypothyroidism in head and neck cancer patients
Background: Head and neck cancers are one of the most common cancers worldwide. Radiotherapy is the only curative treatment, besides surgery. The most common clinical late effect of thyroid gland irradiation in patients...
Mass drug administration coverage evaluation for elimination of lymphatic filariasis in Chhatarpur district of Madhya Pradesh
Background: Mass drug administration (MDA) means administration of diethylcarbamazine (DEC) tablet to all people (excluding children <2 years, pregnant women, seriously ill persons) in endemic areas once in a ye...
Bromocriptine mesylate in type 2 diabetes mellitus: A novel approach
Type 2 diabetes mellitus (T2DM) remains uncontrolled in a large number of patients despite advances in medical treatment. Bromocriptine mesylate is a quick release preparation of bromocriptine, which acts on hypothalamic...
The fatal booze!—triple acid–base disorder in a patient with alcohol intoxication
Patients of chronic alcohol abuse can present with a variety of acid-base disorders and electrolyte disturbances. Lactic acidosis (LA) along with alcoholic ketoacidosis is an infrequent and underappreciated cause of wid...